Clinical Trial Update: Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Update on a Phase 2 trial of NRX 194204 in patients with advanced non-small cell lung cancer; the current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• NRX 194204

Snippet

Sponsor: NuRx Pharmaceuticals, Inc. | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN